WASHINGTON, D.C. (June 24, 2016)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation’s leading home oxygen therapy provider and manufacturing companies—expressed disappointment that the U.S. House of Representatives did not pass the Patient Access to Durable Medical Equipment (PADME) Act (H.R. 5210) before adjourning. The PADME Act is pro-patient legislation to delay the phase-in of deep Medicare cuts to home respiratory care supplies and services.

WASHINGTON, D.C. (June 24, 2016)—Just minutes after AAHomecare updated members about the status of rural relief legislation on Capitol Hill, they received CMS’s announcement of the release of the 2016 DMEPOS fee schedule amounts set to take effect on July 1 for certain items outside of Competitive Bid Areas that were adjusted based on information from the bidding program.

WASHINGTON, D.C. (June 23, 2016)—CMS released a final rule implementing Section 216(a) of the Protecting Access to Medicare Act of 2014 (PAMA), requiring laboratories performing clinical diagnostic laboratory tests to report the amounts paid by private insurers for laboratory tests. Medicare will use these private insurer rates to calculate Medicare payment rates for laboratory tests paid under the Clinical Laboratory Fee Schedule (CLFS) beginning January 1, 2018.

LENEXA, Kan. (June 23, 2016)—EY announced that the president and CEO of Mediware Information Systems, Inc., Kelly Mann, received the EY Entrepreneur Of The Year 2016 Award in the Central Midwest. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.

DENVER (June 23, 2016)—Remote monitoring and automated coaching from ResMed significantly improve the use of continuous positive airway pressure therapy for patients with obstructive sleep apnea, according to an independent Kaiser Permanente study presented last week at the SLEEP conference in Denver—the largest-ever randomized, controlled study on OSA in the United States.